Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 155

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials

Derosa, Giuseppe, Maffioli, Pamela, Simental-Mendía, Luis E., Bo, Simona, Sahebkar, Amirhossein·2016·Pharmacological Research
DOI 10.1016/j.phrs.2016.07.004
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2016.07.004

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 58

  1. Goel, 2008, Curcumin as Curecumin: from kitchen to clinic, Biochem. Pharmacol., 75, 787, 10.1016/j.bcp.2007.08.016 · DOI
  2. Sahebkar, 2016, Curcumin downregulates human tumor necrosis factor-α levels: a systematic review and meta-analysis of randomized controlled trials, Pharmacol. Res., 107, 234, 10.1016/j.phrs.2016.03.026 · DOI
  3. Sahebkar, 2013, Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?, Biofactors, 39, 197, 10.1002/biof.1062 · DOI
  4. Sahebkar, 2014, Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis, Phytother. Res., 28, 633, 10.1002/ptr.5045 · DOI
  5. Schaffer, 2015, An update on Curcuma as a functional food in the control of cancer and inflammation, Curr. Opin. Clin. Nutr. Metab. Care, 18, 605, 10.1097/MCO.0000000000000227 · DOI
  6. Ghosh, 2015, The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update, Food Chem. Toxicol., 83, 111, 10.1016/j.fct.2015.05.022 · DOI
  7. He, 2015, Curcumin, inflammation, and chronic diseases: how are they linked, Molecules, 20, 9183, 10.3390/molecules20059183 · DOI · Paper page
  8. Naz, 2016, Curcumin: a novel non-steroidal contraceptive with antimicrobial properties, Front. Biosci. (Elite Ed.), 8, 113, 10.2741/e755 · DOI
  9. Panahi, 2012, Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial, Br. J. Nutr., 108, 1272, 10.1017/S0007114511006544 · DOI
  10. Rahmani, 2016, Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial, Phytother. Res., 10.1002/ptr.5659 · DOI
  11. Panahi, 2015, Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder, Phytother. Res., 29, 17, 10.1002/ptr.5211 · DOI
  12. Panahi, 2014, Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial, Phytother. Res., 28, 1625, 10.1002/ptr.5174 · DOI · Paper page
  13. Sahebkar, 2010, Molecular mechanisms for curcumin benefits against ischemic injury, Fertil. Steril., 94, e75, 10.1016/j.fertnstert.2010.07.1071 · DOI
  14. Mohammadi, 2013, Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial, Phytother. Res., 27, 374, 10.1002/ptr.4715 · DOI · Paper page
  15. Sahebkar, 2014, Curcuminoids for the management of hypertriglyceridaemia, Nat. Rev. Cardiol., 11, 123, 10.1038/nrcardio.2013.140-c1 · DOI · Paper page
  16. Panahi, 2014, Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial, Complement. Ther. Med., 22, 851, 10.1016/j.ctim.2014.07.006 · DOI
  17. Panahi, 2016, Curcumin lowers serum lipids and uric acid in subjects with non-alcoholic fatty liver disease: a randomized controlled trial, J. Cardiovasc. Pharmacol., 10.1097/FJC.0000000000000406 · DOI
  18. Shakeri, 2016, Optimized curcumin formulations for the treatment of Alzheimer's disease: a patent evaluation, J. Neurosci. Res., 94, 111, 10.1002/jnr.23696 · DOI
  19. Tayyem, 2006, Curcumin content of turmeric and curry powders, Nutr. Cancer, 55, 126, 10.1207/s15327914nc5502_2 · DOI
  20. Devassy, 2015, Curcumin and cancer: barriers to obtaining a health claim, Nutr. Rev., 73, 155, 10.1093/nutrit/nuu064 · DOI
  21. Panahi, 2014, Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial, Phytother. Res., 28, 1461, 10.1002/ptr.5149 · DOI
  22. Mirzaei, 2016, Curcumin: a new candidate for melanoma therapy?, Int. J. Cancer, 10.1002/ijc.30224 · DOI
  23. Momtazi, 2016, Difluorinated curcumin: a promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile, Curr. Pharm. Des.
  24. Devaraj, 2008, Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome, Free Radic. Biol. Med., 44, 1203, 10.1016/j.freeradbiomed.2007.12.018 · DOI · Paper page
  25. Simpson, 1997, Interleukin-6: structure-function relationships, Protein Sci., 6, 929, 10.1002/pro.5560060501 · DOI
  26. Devi, 2015, Inhibition of IL-6 signaling pathway by curcumin in uterine decidual cells, PLoS One, e0125627, 10.1371/journal.pone.0125627 · DOI
  27. Chen, 2015, Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis, Biochem. Biophys. Res. Commun., 467, 872, 10.1016/j.bbrc.2015.10.051 · DOI
  28. Kondamudi, 2015, Curcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease, Pharmacogn. Mag., 11, S292
  29. Singh, 2015, Curcumin attenuates CFA induced thermal hyperalgesia by modulation of antioxidant enzymes and down regulation of TNF-α, IL-1β and IL-6, Neurochem. Res., 40, 463, 10.1007/s11064-014-1489-6 · DOI
  30. Miao, 2016, Curcumin pretreatment attenuates inflammation and mithocondrial dysfunction in experimental stroke: the possible role of Sirt1 signaling, Brain Res. Bull., 121, 9, 10.1016/j.brainresbull.2015.11.019 · DOI
  31. Morrone Mda, 2016, Curcumin supplementation decreases intestinal adiposity accumulation, serum cholesterol alterations, and oxidative stress in ovariectomized rats, Oxid. Med. Cell Longev., 2016, 5719291
  32. Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535 · DOI · Paper page
  33. J.P.T. Higgins, S. Green, (eds.), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2. London: The Cochrane Collaboration; 2011
  34. Dinca, 2016, Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials, Pharmacol. Res., 107, 360, 10.1016/j.phrs.2016.03.035 · DOI
  35. Ferretti, 2015, Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials, Prog. Lipid Res., 60, 50, 10.1016/j.plipres.2015.08.003 · DOI
  36. Duval, 2000, Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis, Biometrics, 56, 455, 10.1111/j.0006-341X.2000.00455.x · DOI · Paper page
  37. Belcaro, 2010, Efficacy and safety of Meriva®: a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients, Altern. Med. Rev., 15, 337
  38. Na, 2014, Curcuminoids target decreasing serum adipocyte-fatty acid binding protein levels in their glucose-lowering effect in patients with type 2 diabetes, Biomed. Environ. Sci., 27, 902
  39. Usharani, 2008, Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study, Drugs RD, 9, 243, 10.2165/00126839-200809040-00004 · DOI
  40. Ganjali, 2014, Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial, Sci. World J., 2014, 898361, 10.1155/2014/898361 · DOI
  41. Panahi, 2012, A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications, Ann. Clin. Biochem., 49, 580, 10.1258/acb.2012.012040 · DOI
  42. Panahi, 2016, Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post-hoc analysis of a randomized controlled trial, Biomed. Pharmacother., 05, 037
  43. Panahi, 2015, Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: positive results of a randomized double-blind placebo-controlled trial, Drug Res. (Stuttg.), 65, 567
  44. Rahimnia, 2015, Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: findings from a randomized double-blind placebo-controlled trial, Drug Res. (Stuttg.), 65, 521
  45. Chainani-Wu, 2012, High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus, J. Am. Acad. Dermatol., 66, 752, 10.1016/j.jaad.2011.04.022 · DOI
  46. Gupta, 2014, Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols, Arch. Biochem. Biophys., 559, 91, 10.1016/j.abb.2014.06.006 · DOI
  47. Aggarwal, 2013, Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers, Br. J. Pharmacol., 169, 1672, 10.1111/bph.12131 · DOI · Paper page
  48. Creţu, 2012, Plant-derived anticancer agents⿿curcumin in cancer prevention and treatment, Rev. Med. Chir. Soc. Med. Nat. Iasi, 116, 1223
  49. Cho, 2007, Curcumin attenuates the expression of IL-1beta: IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets, Int. J. Mol. Med., 19, 469
  50. Srimal, 1973, Pharmacology of diferuloyl methane (curcumin): a non-steroidal anti-inflammatory agent, J. Pharm. Pharmacol., 25, 447, 10.1111/j.2042-7158.1973.tb09131.x · DOI · Paper page
  51. Gupta, 2013, Therapeutic roles of curcumin: lessons learned from clinical trials, AAPS J., 15, 195, 10.1208/s12248-012-9432-8 · DOI · Paper page
  52. Schaper, 2015, Interleukin-6: Biology, signaling and strategies of blockade, Cytokine Growth Factor Rev., 26, 475, 10.1016/j.cytogfr.2015.07.004 · DOI
  53. Kang, 2015, Therapeutic uses of anti-interleukin-6 receptor antibody, Int. Immunol., 27, 21, 10.1093/intimm/dxu081 · DOI
  54. Ren, 2009, Effect of simvastatin on plasma interleukin-6 in patients with unstable angina, Clin. Invest. Med., 32, E280, 10.25011/cim.v32i4.6619 · DOI
  55. Bulcão, 2007, Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome, Am. J. Cardiovasc. Drugs, 7, 219, 10.2165/00129784-200707030-00007 · DOI
  56. Ikonomidis, 1999, Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin, Circulation, 100, 793, 10.1161/01.CIR.100.8.793 · DOI · Paper page
  57. Nishina, 2013, Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression, Clin. Rheumatol., 32, 1661, 10.1007/s10067-013-2309-0 · DOI
  58. Yallapu, 2015, Therapeutic applications of curcumin nanoformulations, AAPS J., 17, 1341, 10.1208/s12248-015-9811-z · DOI

Cited by

Metadata

Authors
Derosa, G., Maffioli, P., Simental-Mendía, L. E., Bo, S., & Sahebkar, A.
Venue
Pharmacological Research
Publisher
Elsevier BV
Published
2016-09
Volume
111
Pages
394-404
ISSN
1043-6618
DOI
10.1016/j.phrs.2016.07.004
Cited by
155
References
4
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.